Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0

作者：

Menzies-Gow, Andrew ^{[1
]}

Corren, Jonathan ^{[2
]}

Bourdin, Arnaud ^{[3
]}

Chupp, Geoffrey ^{[4
]}

Israel, Elliot ^{[5
,6
]}

Griffiths, Janet ^{[7
]}

Hellqvist, Asa ^{[8
]}

Bowen, Karin ^{[9
]}

Kaur, Primal ^{[10
]}

Almqvist, Gun ^{[11
]}

Ponnarambil, Sandhia ^{[12
]}

Colice, Gene ^{[13
]}

机构：

[1] Royal Brompton Hosp, London, England

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] CHU Montpellier, Hop Arnaud Villeneuve, Montpellier, France

[4] Yale Sch Med, New Haven, CT USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[7] AstraZeneca, Translat Sci & Expt Med, Res & Early Dev, Resp & Immunol,BioPharmaceut R&D, Gaithersburg, MD USA

[8] AstraZeneca, BioPharmaceut R&D, Biometr Late Resp & Immunol, Gothenburg, Sweden

[9] Astrazeneca, BioPharmaceuticals R&D, Biometr Late Resp & Immunol, Gaithersburg, MD USA

[10] Amgen Inc, Thousand Oaks, CA USA

[11] AstraZeneca, Late Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden

[12] AstraZeneca, BioPharmaceut R&D, Late Resp & Immunol, Cambridge, England

[13] AstraZeneca, Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

L46

引用

页码：AB249 / AB249

页数：1

共 50 条

[41] TEZEPELUMAB EFFICACY ACCORDING TO US OMALIZUMAB ELIGIBILITY: RESULTS FROM THE NAVIGATOR PHASE 3 STUDY
Israel, E.
Chupp, G.
Colice, G.
Cook, B.
Ambrose, C.
Roseti, S.
Hellqvist, A.
Llanos-Ackert, J.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S14 - S15
[42] Efficacy of Tezepelumab in Patients with Moderate-to-Severe Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
Corren, J.
Menzies-Gow, A.
Ambrose, C.
Cook, W.
Hellquist, A.
Roseti, S.
Molfinao, N.
Lanos-Ackert, P. J.
Colice, G.
[J]. PNEUMOLOGIE, 2022, 76 : S14 - S14
[43] Effect Of Tezepelumab On Rescue Medication Use And Night-Time Awakenings In Patients With Severe, Uncontrolled Asthma: Results From The NAVIGATOR Study
Carr, Warner
Ambrose, Chris
Hunter, Gillian
Ponnarambil, Sandhia
Llanos-Ackert, Jean-Pierre
Clarke, Nicole
Cook, Bill
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB14 - AB14
[44] Clinically Meaningful Improvements in St George's Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
Kraft, M.
Corren, J.
Ambrose, C. S.
Cook, B.
Clarke, N.
Hunter, G.
Molfino, N.
Ponnarambil, S.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[45] Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR
Jacobs, Joshua
Hoyte, Flavia
Spahn, Joseph
Ambrose, Chris
Martin, Nicole
Vong, Sylvia
Caveney, Scott
Cook, Bill
Colice, Gene
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB17 - AB17
[46] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
Corren, Jonathan
Mathur, Sameer K.
Carr, Tara F.
Wardlaw, Andrew J.
Caminati, Marco
Martin, Nicole
Ponnarambil, Sandhia
Lindsley, Andrew W.
Spahn, Joseph D.
Martin, Neil
Geffen, David
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
[47] The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
Corren, J.
Menzies-Gow, A.
Ambrose, C. S.
Cook, B.
Kmita, K.
Colice, G.
Llanos-Ackert, J.
[J]. ALLERGY, 2021, 76 : 13 - 14
[48] EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
Hill, J.
Carr, T.
Ambrose, C.
Martin, N.
Ponnarambil, S.
Lindsley, A.
Martin, N.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S35 - S35
[49] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy
Corren, Jonathan
Ambrose, Christopher S.
Salapa, Kinga
Roseti, Stephanie L.
Griffiths, Janet M.
Parnes, Jane R.
Colice, Gene
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4334 - +
[50] Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)
Pavord, Ian D.
Hoyte, Flavia C. L.
Lindsley, Andrew W.
Ambrose, Christopher S.
Spahn, Joseph D.
Roseti, Stephanie L.
Cook, Bill
Grif, Janet M.
Hellqvist, Asa
Martin, Nicole
Llanos, Jean-Pierre
Martin, Neil
Colice, Gene
Corren, Jonathan
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : 587 - 597.e3

← 1 2 3 4 5 →